A pediatric case of anaphylaxis due to octreotide

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 4, 2011, Pages 361-636

  Azkur, Dilek ^a   Yoldas, Tamer ^b   Toyran, Muge ^a   Kocabas, Can Naci ^a  

^a Department of Pediatric Allergy and Immunology ^*  (Turkey)

^b Research Hospital   (Turkey)

Author keywords

Anaphylaxis; Child; Desensiti zation; Octreotide; Pancreatitis

Indexed keywords

ALPHA AMYLASE PANCREAS ISOENZYME; OCTREOTIDE; PHENIRAMINE MALEATE; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; AMYLASE BLOOD LEVEL; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD PRESSURE MONITORING; CASE REPORT; CHILD; CHRONIC PANCREATITIS; COUGHING; DESENSITIZATION; DISEASE EXACERBATION; DYSPNEA; ERYTHEMA; FLUSHING; HEART RATE; HUMAN; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; PRICK TEST; PULSE OXIMETRY; RESUSCITATION; SCHOOL CHILD; SWELLING; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ANAPHYLAXIS; CHILD; DESENSITIZATION, IMMUNOLOGIC; GASTROINTESTINAL AGENTS; HUMANS; MALE; OCTREOTIDE; PANCREATITIS, CHRONIC; SKIN TESTS;

EID: 84855246418     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fleseriu M. Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary. 2011;14:184-93.
2. Khuroo MS, Khuroo MS, Khuroo NS. Treatment of type I gastric neuroendocrine tumors with somatostatin analogs. J Gastroenterol Hepatol. 2010;25:548-54.
3. Song S, Shi R, Li B, Liu Y. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors. Pancreas. 2009;38:811-4.
4. Tatar T, Kilic D, Ozkan M, Hatipoglu A, Aslamaci S. Management of Chylothorax with Octreotide after Congenital Heart Surgery. Thorac Cardiovasc Surg. 2011;59:298-301.
5. Benson AB 3rd, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA Jr, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004;22:2918-26.
6. Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP. Control of irinotecan-induced diarrhea by octreotide after loperamide failure. Support Care Cancer. 2001;9:258-60.
7. Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, et al. Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci. 2000;45:2247-51.
8. Fiedler F, Jauernig G, Keim V, Richter A, Bender HJ. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure. Intensive Care Med. 1996;22:909-15.
9. Lieb JG 2nd, Shuster JJ, Theriaque D, Curington C, Cintrón M, Toskes PP. A pilot study of Octreotide LAR vs. octreotide tid for pain and quality of life in chronic pancreatitis. JOP. 2009;10:518-22.
10. Novartis. Sandostatin (octreotide acetate) package insert, East Hanover, New Jersey, January 2010.
11. eHealthMe: Real world drug outcomes [Internet]. [place unknown]: eHealthMe; c 2011. Octreotide acetate side effect: Anaphylaxis; [cited 2011 July 10]; [about 1 screens]. Available from:http://www.ehealthme.com/ds/octreotide+acetate/anaphylaxis
12. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006;47:373-80.
13. Lieberman P. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8:316-20.
14. Moro Moro M, Tejedor Alonso MA, Esteban Hernández J, Múgica García MV, Rosado Ingelmo A, Vila Albelda C. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol. 2011;21:142-9.